---
figid: PMC11464892__41598_2024_74558_Fig7_HTML
figtitle: IL-17 signaling pathway in CD 138 + MM cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11464892
filename: 41598_2024_74558_Fig7_HTML.jpg
figlink: /pmc/articles/PMC11464892/figure/F7/
number: F7
caption: IL-17 signaling pathway in CD 138 + MM cells. Green—statistically significant
  increase in expression, red—statistically significant decrease in expression. IL-17
  signaling pathway was obtained from The KEGG pathway database64–66
papertitle: Deep hematologic response to RD treatment in patients with multiple myeloma
  is associated with overexpression of IL-17R in CD138+ plasma cells
reftext: Piotr Kulig, et al. Sci Rep. 2024;14(NA).
year: '2024'
doi: 10.1038/s41598-024-74558-3
journal_title: Scientific Reports
journal_nlm_ta: Sci Rep
publisher_name: Nature Publishing Group
keywords: Multiple myeloma | Lenalidomide | IL-17 | Good response to therapy | Tumor
  niche | Immune response | Bone marrow microenvironment | Myeloma | Cancer | Cancer
  microenvironment
automl_pathway: 0.8446031
figid_alias: PMC11464892__F7
figtype: Figure
redirect_from: /figures/PMC11464892__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11464892__41598_2024_74558_Fig7_HTML.html
  '@type': Dataset
  description: IL-17 signaling pathway in CD 138 + MM cells. Green—statistically significant
    increase in expression, red—statistically significant decrease in expression.
    IL-17 signaling pathway was obtained from The KEGG pathway database64–66
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL17A
  - IL25
  - CD4
  - SPACA9
  - SPG21
  - CD8A
  - CD8B
  - CASP8
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - SERPINA3
  - ACTG1
  - ACTG2
  - FHL5
  - ACOT7
  - ACTBL2
  - POTEKP
  - POTEM
  - FADD
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - CCL17
  - APP
  - TNFAIP3
  - IGKV1-27
  - RPL17
  - TPGS2
  - IGKV2D-14
  - IL17RC
  - TH
  - USP25
  - TANK
  - SRSF1
  - TAB2
  - TAB3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL2
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - TNF
  - CSF3
  - S100A7
  - MMP3
  - MMP9
  - MMP1
  - MMP2
  - MMP7
  - MMP8
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - IL17C
  - IL17RE
  - ARIH1
  - TTK
  - IFNA1
  - IL17D
  - DNA
  - ABL
  - Antimicrobial
  - ARI
---
